Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

theguardian.com - Linda Geddes - Why pharma firms are going to Earth's orbit in search of new cancer drugs
Why pharma firms are going to Earth's orbit in search of new cancer drugs
The Guardian –

Roughly 300 miles above our heads, three washing machine-sized capsules are orbiting the Earth. Inside one of them, tiny crystals of a potential cancer drug are being grown in the weightlessness of space. The others are testing heat protection…

bloomberg.com - Madison Muller - Pfizer Raises 2026 Forecast, Extending Big Pharma Windfall
Pfizer Raises 2026 Forecast, Extending Big Pharma Windfall
Bloomberg –

Pfizer Inc. raised its full-year outlook after it outperformed in the third quarter, as growing demand for its newer medicines helped the drugmaker offset declining sales of its Covid products. The drugmaker now expects full-year revenue of $62…

whtc.com - Thomson Reuters - India's Alembic Pharma profit jumps on strong US sales
India's Alembic Pharma profit jumps on strong US sales
92.7 FM WHTC | Holland –

By Thomson Reuters Nov 4, 2026 | 4:50 AM Nov 4 (Reuters) – India's Alembic Pharmaceuticals posted an 81% rise in second-quarter profit ​on Wednesday, helped by ‌strong sales in the US market, sending its shares surging 20%.

fool.com - Motley Fool Transcribing - Rhythm Pharma (RYTM) Q3 2026 Earnings Call Transcript
Rhythm Pharma (RYTM) Q3 2026 Earnings Call Transcript
The Motley Fool –

Head of Investor Relations - Dave Connolly Chairman, Chief Executive Officer, and President - David Meeker Executive Vice President, Head of North America - Jennifer Lee Chief Financial Officer - Hunter Smith Executive Vice President, Head of…

dynamitenews.com - Pradeep Tripathi - Yogi Government Plans 200-Acre Bio-Pharma Park in Pilibhit to Boost UP's Pharmaceutical Industry | Dynamite News
Yogi Government Plans 200-Acre Bio-Pharma Park in Pilibhit to Boost UP's Pharmaceutical Industry | Dynamite News
News: Today's News Headlines & Daily Updates from Sports, Movies, Politics, Business | Dynamite News –

Post Published By: Pradeep Tripathi Updated: 3 November 2026, 7:39 PM IST Lucknow: The Yogi government is stepping up efforts to establish Uttar Pradesh as a major hub for pharmaceutical and biotechnology manufacturing. As part of this initiative…

thehindu.com -  The Hindu Bureau - HRV Pharma to acquire German firm Phatebo
HRV Pharma to acquire German firm Phatebo
The Hindu –

HRV Pharma, a virtual pharmaceutical company headquartered in Hyderabad, is acquiring Phatebo GmbH, a licensed pharmaceutical wholesaler in Germany specialising in clinical trial supply. The acquisition will take it beyond active pharmaceutical…

newswire.ca - Spektus Pharma and GEBRO Holding Announce Global Commercialization Partnership for ActraFlex
Spektus Pharma and GEBRO Holding Announce Global Commercialization Partnership for ActraFlex
CNW –

Novel twice-daily extended-release tramadol/paracetamol formulation combines Spektus' proprietary AmyloFlex technology with GEBRO's established Diliban brand. LAVAL, QC and FIEBERBRUNN, Austria, Nov. 3, 2026 /CNW/ -- Spektus Pharma Inc. ('Spektus')…

thehindubusinessline.com - Madhu Balaji - Emcure Pharma shares hit 10% upper circuit as Q2 net profit rises
Emcure Pharma shares hit 10% upper circuit as Q2 net profit rises
The HinduBusinessLine –

Updated - November 04, 2026 at 10:26 AM. | Bengaluru Emcure Pharmaceuticals shares rallied 10 per cent to hit the upper circuit on Wednesday after the company reported a 29.31 per cent increase in consolidated net profit to ₹325.06 crore in…

marketbeat.com - Spyglass Pharma (NASDAQ:SGP) Hits New 1-Year High - What's Next?
Spyglass Pharma (NASDAQ:SGP) Hits New 1-Year High - What's Next?
MarketBeat –

Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) shares reached a new 52-week high on Tuesday. The stock traded as high as $34.24 and last traded at $34.6730, with a volume of 1,557 shares traded. The stock had previously closed at $33.64. SGP…

marketbeat.com - 147,113 Royalty Pharma PLC $RPRX Shares Sold by Sumitomo Mitsui Trust Group Inc.
147,113 Royalty Pharma PLC $RPRX Shares Sold by Sumitomo Mitsui Trust Group Inc.
MarketBeat –

Sumitomo Mitsui Trust Group Inc. reduced its position in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 12.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…

contentmarketinginstitute.com -  Robert Rose - 2027 B2B Content Marketing Trends Report | CMI
2027 B2B Content Marketing Trends Report | CMI
Content Marketing Institute –

Every marketer over 40 knows one particular episode of I Love Lucy (and every marketer under 40 has seen the GIF). Lucy and Ethel take jobs at a candy factory, wrapping chocolates coming down a conveyor belt. If they miss a single one, they'll be…

nbcnews.com - Republican Gov. Kelly Ayotte secures re-election in New Hampshire
Republican Gov. Kelly Ayotte secures re-election in New Hampshire
NBC News –

Republican Gov. Kelly Ayotte has won a second two-year term in New Hampshire, a state that has trended blue at the national level, NBC News projects. Ayotte fended off a challenge from Democrat Cinde Warmington, a former state Executive Council…

theconversation.com - Anna Mate - From industrial powerhouse to uncertain future: lessons from Britain's chemical industry
From industrial powerhouse to uncertain future: lessons from Britain's chemical industry
The Conversation –

In 1989 a young Janet Godsell, one of the authors of this article, spent a week on night shifts in the powerhouse at ICI's Huddersfield works in west Yorkshire. She was starting her career at the biggest chemicals company in the UK, but it would be…

seekingalpha.com - Justin Miller - Eli Lilly: Priced For Acceleration, Reporting Deceleration (NYSE:LLY)
Eli Lilly: Priced For Acceleration, Reporting Deceleration (NYSE:LLY)
Seeking Alpha –

Eli Lilly delivered strong Q3 results, but underlying growth slowed from 49% to 35% and price erosion deepened. LLY's growth engine is narrowing: the US faces worsening price declines, while international volume growth is decelerating. At $1,405…

washingtonexaminer.com - David Sivak - Republican Kelly Ayotte wins second term as New Hampshire governor
Republican Kelly Ayotte wins second term as New Hampshire governor
Washington Examiner –

Gov. Kelly Ayotte (R-NH) has kept New Hampshire's governorship in Republican hands, winning a second two-year term despite the political headwinds facing her party nationally. Ayotte defeated Democratic challenger Cinde Warmington with 51.1% of the…

Receive a Daily briefing on Pharma Industry News

Get Started